Reviewed by the Celnovix Editorial Team
Last reviewed: September 2026
NMN and Urolithin A are often discussed together in the longevity supplement space.
That makes sense at first glance.
Both are connected to cellular metabolism. Both have attracted attention in healthy-aging research. Both are commonly discussed in relation to mitochondria.
But they are not doing the same thing.
NMN is primarily studied as a precursor involved in NAD+ metabolism.
Urolithin A is primarily studied for its relationship with mitochondrial quality control and mitophagy-related pathways.
That difference matters.
It means comparing NMN and Urolithin A is not like comparing two versions of the same ingredient.
The more useful question is:
Which biological pathway—and which human evidence—is most relevant to the outcome you care about?
Quick Answer: NMN vs Urolithin A
NMN
Human research is primarily centered on:
- Increasing NAD+ or NAD-related metabolites
- NAD+-dependent cellular biology
- Energy metabolism
- Insulin sensitivity
- Physical performance
- Healthy-aging research
Urolithin A
Human research is more focused on:
- Mitophagy-related pathways
- Mitochondrial quality control
- Muscle endurance
- Certain measures of muscle strength
- Mitochondrial biomarkers
- Healthy muscle aging
The biggest difference
NMN is a precursor used in NAD+ biosynthesis.
Urolithin A is a gut microbiome-derived metabolite being studied for mitochondrial quality control.
Neither has been proven to:
- Reverse aging
- Extend human lifespan
- Prevent age-related disease broadly
- Replace exercise or healthy nutrition
- Guarantee higher energy
- Work better simply because two mechanisms sound complementary
What Is NMN?
NMN stands for nicotinamide mononucleotide.
It is a naturally occurring nucleotide involved in the body’s production of nicotinamide adenine dinucleotide, or NAD+.
NAD+ is an essential cellular coenzyme involved in processes including:
- Energy metabolism
- Oxidation-reduction reactions
- DNA repair
- Cellular signaling
- Sirtuin activity
- PARP activity
Interest in NMN grew largely because NAD+ metabolism changes with age and because animal studies suggested that increasing NAD+ availability might influence several aging-associated processes.
That led to a major commercial idea:
If NAD+ declines with age, perhaps increasing NAD+ through NMN could improve healthy aging.
The first half of that statement has biological support.
The second half is still being tested in humans.
Does NMN Actually Increase NAD+ in Humans?
Yes—this is one of the more consistent findings in the human literature.
Randomized and controlled studies have reported increases in circulating NAD+ or related metabolites following oral NMN supplementation.
For example, a placebo-controlled trial in healthy adults found that 250 mg NMN per day for 12 weeks significantly increased whole-blood NAD+ levels.
View the clinical trial on PubMed
Another study in healthy volunteers also reported increased plasma NMN and NAD+ concentrations following 12 weeks of supplementation.
More importantly, a 2025 systematic review and meta-analysis of randomized controlled trials found that NMN supplementation significantly increased blood NAD levels.
However, that review also found that most clinically relevant glucose and lipid outcomes were not significantly different from controls.
Read the systematic review on PubMed
This distinction is essential:
Raising NAD+ is a biological effect.
It is not automatically proof of:
- Longer lifespan
- Improved metabolic health
- Increased strength
- Weight loss
- Reversal of aging
What Is Urolithin A?
Urolithin A is a metabolite produced when certain gut bacteria transform compounds called ellagitannins and ellagic acid.
These precursor compounds are found in foods such as:
- Pomegranates
- Walnuts
- Raspberries
- Strawberries
- Blackberries
But not everyone produces the same amount of Urolithin A after eating these foods.
Gut microbiome composition influences the conversion process.
That is why direct Urolithin A supplementation has become an area of research.
Much of the interest centers on mitophagy.
Mitophagy is a cellular quality-control process involved in identifying and recycling dysfunctional mitochondria.
For more on natural production, read:
Foods Rich in Urolithin A: Natural Sources and What to Know
For the broader clinical evidence:
Urolithin A Benefits: What Does the Research Actually Show?
NMN vs Urolithin A: Side-by-Side Comparison
|
Feature |
NMN |
Urolithin A |
|---|---|---|
|
Full name |
Nicotinamide Mononucleotide |
Urolithin A |
|
Compound type |
NAD+ precursor |
Gut microbiome-derived metabolite |
|
Main research pathway |
NAD+ metabolism |
Mitophagy and mitochondrial quality control |
|
Naturally produced in body |
Yes, as part of NAD metabolism |
Can be produced by gut bacteria |
|
Depends on gut bacteria |
Not primarily |
Yes for dietary production |
|
Raises blood NAD+ |
Human evidence supports this |
Not its primary role |
|
Muscle research |
Some human studies |
Major clinical research focus |
|
Mitochondrial research |
Yes, indirectly through NAD biology |
Central research focus |
|
Human evidence base |
Growing |
Smaller and newer |
|
Proven to extend lifespan |
No |
No |
|
Proven anti-aging treatment |
No |
No |
|
Head-to-head NMN vs UA trial |
No established high-quality trial |
No |
NMN vs Urolithin A: The Biological Difference
A useful way to understand the comparison is:
NMN supports the NAD+ pool.
Urolithin A is being studied for mitochondrial quality control.
These are related areas of cellular biology, but they are not the same pathway.
NAD+ participates in numerous biochemical reactions throughout the cell.
Mitophagy is a more specific cellular quality-control process involving mitochondria.
That means it is overly simplistic to say:
“NMN gives cells energy while Urolithin A cleans mitochondria.”
That wording may be easy to market.
It is not a precise description of human physiology.
Which Is Better for NAD+?
NMN.
This is the clearest difference between the two.
NMN is directly involved in NAD+ biosynthesis and multiple human studies have shown that oral supplementation can increase circulating NAD+ or related metabolites.
Urolithin A is not primarily used as an NAD+ precursor.
If the research question is specifically:
“Which compound is more directly associated with increasing NAD+?”
NMN has the stronger mechanistic and human evidence.
But an important caution remains:
Higher NAD+ does not automatically equal better clinical outcomes.
A 2025 meta-analysis of 12 studies involving 513 participants found a significant increase in blood NAD but did not find significant benefits across most glucose and lipid outcomes.
View the meta-analysis on PubMed
Which Is Better for Mitophagy?
Urolithin A.
More precisely:
Urolithin A has a much stronger research identity around mitophagy than NMN.
A first-in-human Urolithin A study published in Nature Metabolism reported molecular signatures associated with improved mitochondrial and cellular health.
Read the Nature Metabolism study
Later human trials examined:
- Muscle endurance
- Muscle strength
- Mitochondrial biomarkers
- Physical performance
But even here, the evidence should not be overstated.
A 2026 systematic review and meta-analysis found only five randomized controlled trials involving 236 participants.
The pooled 6-minute walk test result was directionally favorable but not statistically conclusive, and the certainty of evidence was rated low.
View the 2026 systematic review on PubMed
So Urolithin A has a stronger research focus on mitophagy—but that does not mean every claimed mitophagy benefit has been clinically proven.
Which Is Better for Mitochondrial Health?
There is no simple winner.
Both compounds relate to mitochondrial biology in different ways.
NMN
NAD+ is essential for:
- Cellular redox reactions
- Energy metabolism
- Enzyme activity
- Cellular signaling
Because mitochondria depend heavily on NAD-related metabolism, NMN can indirectly influence mitochondrial biology through NAD+ availability.
Urolithin A
The research is more directly focused on:
- Mitochondrial quality control
- Mitophagy-related pathways
- Mitochondrial biomarkers
- Muscle mitochondrial health
Verdict
NMN is more directly tied to NAD+ availability. Urolithin A has a more specific research focus around mitochondrial quality control.
There is no high-quality head-to-head clinical trial demonstrating that one is universally better for “mitochondrial health.”
Which Is Better for Muscle Health?
This is an area where Urolithin A currently has a clearer research focus.
A randomized trial in older adults investigated 1,000 mg Urolithin A per day for four months.
Researchers reported improvements in some measures of muscle endurance, though the trial’s primary endpoints involving 6-minute walking distance and maximal ATP production did not significantly improve versus placebo.
Read the JAMA Network Open trial
Another randomized trial in middle-aged adults examined 500 mg and 1,000 mg per day and found improvements in some strength measures, although not every physical-performance outcome improved.
Read the Cell Reports Medicine trial
What about NMN?
NMN has also been studied for physical performance.
A 2024 systematic review included 10 randomized trials and 437 participants.
The review reported that physical-performance parameters showed small or non-significant improvements overall, and concluded that larger studies were needed.
View the systematic review on PubMed
Individual NMN studies have reported findings such as:
- Changes in gait speed
- Walking performance
- Grip-related outcomes
- Blood NAD+
But results have not been consistent across studies.
For example, one trial in older adults found no significant group difference in the primary stepping-test endpoint, although a secondary 4-meter walking outcome and NAD+ measures improved.
Verdict
Urolithin A currently has a more concentrated body of human research focused specifically on muscle and mitochondrial outcomes. NMN has some promising physical-function signals, but they are not yet consistent enough to establish superiority.
Which Is Better for Energy?
Neither should be treated as a stimulant.
NMN
Because NAD+ is central to cellular energy metabolism, NMN is often marketed as an “energy” supplement.
But raising NAD+ does not mean someone will necessarily feel an immediate increase in energy.
Urolithin A
Urolithin A is studied in relation to mitochondrial quality control and muscle function.
It also does not behave like caffeine.
Verdict
Neither NMN nor Urolithin A has been established as a reliable acute energy booster.
Which Is Better for Metabolic Health?
NMN has been studied more directly in relation to glucose and insulin metabolism.
Some individual studies have generated positive findings.
For example, research in specific populations has investigated muscle insulin sensitivity.
However, broader evidence is much less impressive than supplement marketing often suggests.
A 2024 meta-analysis of eight randomized controlled trials involving 342 middle-aged or older adults found no significant effect of short-term NMN supplementation on:
- Fasting glucose
- Fasting insulin
- HbA1c
- HOMA-IR
- Lipid profile
Read the meta-analysis on PubMed
A larger 2025 analysis reached a similar conclusion: blood NAD increased, but most clinically relevant metabolic outcomes did not significantly differ from controls.
View the 2025 review on PubMed
Urolithin A
Urolithin A studies have reported changes in some metabolic biomarkers, including acylcarnitines and inflammatory markers.
But metabolic disease is not currently the strongest area of its clinical evidence.
Verdict
NMN has more direct metabolic research, but broad metabolic benefits have not been consistently demonstrated.
Which Is Better for Insulin Sensitivity?
This question requires extra caution.
One influential human trial reported improved skeletal-muscle insulin sensitivity after NMN supplementation in postmenopausal women with prediabetes.
That result generated considerable interest.
But one study does not establish a universal effect.
Later systematic reviews and meta-analyses examining multiple randomized trials have not found consistent improvements in fasting glucose, insulin, HOMA-IR, or other metabolic outcomes across broader populations.
Therefore:
NMN may affect insulin-related pathways in certain populations, but it is not established as a treatment for insulin resistance or diabetes.
Urolithin A currently has even less evidence supporting use for this purpose.
Which Is Better for Healthy Aging?
Neither compound has been proven to slow human aging.
That is the most important point.
Both are scientifically interesting because they influence biological processes associated with aging.
NMN is relevant to:
- NAD+ metabolism
- Cellular signaling
- Energy metabolism
- DNA-repair-associated pathways
Urolithin A is relevant to:
- Mitophagy
- Mitochondrial quality control
- Muscle function
- Cellular metabolic signaling
But neither has demonstrated in rigorous human trials that it:
- Reverses biological aging
- Extends lifespan
- Prevents age-related disease broadly
- Produces whole-body rejuvenation
A 2026 systematic review of NAD+-boosting approaches reviewed human and preclinical evidence and emphasized that translation of NAD+-related biology into established anti-aging outcomes remains incomplete.
View the 2026 NAD+ systematic review on PubMed
Which Has Better Human Evidence?
That depends on what you measure.
NMN
There are now more human trials examining:
- Safety
- NAD+ levels
- Metabolism
- Physical function
- Glucose regulation
Urolithin A
There are fewer trials overall, but the research program is more concentrated around:
- Mitochondrial biology
- Muscle endurance
- Muscle strength
- Physical performance
A useful distinction is:
NMN has a broader and growing clinical evidence base.
Urolithin A has a smaller but more focused muscle-mitochondrial evidence base.
Neither evidence base is mature enough to support strong anti-aging claims.
NMN vs Urolithin A for Physical Performance
Both have been studied here.
NMN
Human trials have reported mixed findings.
Some studies have suggested possible changes in:
- Walking speed
- Exercise-related outcomes
- Grip performance
But systematic review findings remain modest.
Urolithin A
Some randomized trials have reported improvements in:
- Muscle endurance
- Hamstring strength
- Aerobic measurements
But again, not every primary endpoint has improved.
The latest 2026 Urolithin A meta-analysis concluded that current results are better considered exploratory signals rather than reproducible proof of efficacy.
View the 2026 analysis on PubMed
Verdict
Neither compound has enough evidence to be considered a proven performance enhancer.
Which Is Better After Age 50?
There is no evidence-based rule saying:
“Take NMN after 50”
or:
“Urolithin A becomes better after 50.”
Both have been studied in middle-aged and older adults.
However, research populations vary significantly.
Age alone does not determine whether supplementation is appropriate.
Other considerations include:
- Nutrition
- Physical activity
- Medications
- Health conditions
- Sleep
- Muscle mass
- Cardiovascular status
- Personal goals
For older adults, maintaining muscle mass and function through resistance training, sufficient protein, and regular physical activity has a much stronger evidence base than either supplement.
Which Is Better After Age 60?
The same principle applies.
Older age increases interest in:
- NAD+ metabolism
- Muscle loss
- Mitochondrial function
- Physical performance
But this does not create an automatic need for either supplement.
Some Urolithin A studies specifically enrolled older adults.
Some NMN studies also focused on older populations.
The evidence remains insufficient to recommend one compound universally on the basis of age alone.
NMN vs Urolithin A Dosage
There is no meaningful milligram-to-milligram comparison.
NMN
Human clinical trials have used a wide range of doses.
Recent systematic reviews have included trials using roughly:
150–2,000 mg per day, depending on the study.
That does not mean every dose in this range is appropriate for routine use.
Urolithin A
Notable human trials have used:
- 500 mg/day
- 1,000 mg/day
among other research doses.
For a detailed review, read:
Urolithin A Dosage Guide: How Much Should You Take?
Clinical study doses are not personal dosage recommendations.
What Is the Best Time to Take Them?
Timing evidence is limited for both compounds.
For Urolithin A, there is no high-quality evidence showing that morning is universally superior to evening use.
Read:
Best Time to Take Urolithin A: Morning or Night?
NMN timing has also been studied less rigorously than many online articles imply.
Some trials administer NMN in the morning, but that does not prove morning supplementation produces better clinical outcomes than evening supplementation.
Consistency and following product instructions are more evidence-aligned than claiming a universal optimal hour.
Can You Take NMN and Urolithin A Together?
Possibly—but this is one of the areas where marketing tends to run ahead of evidence.
The theoretical argument is straightforward:
NMN
Supports NAD+ metabolism.
Urolithin A
Targets pathways related to mitochondrial quality control.
Since the mechanisms differ, it is tempting to conclude that taking them together must provide broader cellular support.
But that conclusion has not been demonstrated in high-quality human trials.
There is currently insufficient evidence from randomized studies directly comparing:
- NMN alone
- Urolithin A alone
- NMN + Urolithin A
- Placebo
Therefore:
Different biological mechanisms do not automatically equal proven synergy.
For a deeper discussion, read:
Can You Take NMN and Urolithin A Together? A Complete Guide
NMN + Urolithin A + Resveratrol?
This is another popular “longevity stack.”
The theoretical model usually looks like:
NMN
NAD+ metabolism
Urolithin A
Mitophagy and mitochondrial quality control
Resveratrol
Polyphenol signaling and sirtuin-related research
It looks scientifically sophisticated.
But a pathway diagram is not a clinical trial.
There is insufficient human evidence demonstrating that combining all three:
- Extends lifespan
- Slows aging
- Produces greater benefits than individual compounds
- Improves clinical outcomes in healthy adults
For the direct comparison with Resveratrol, read:
Urolithin A vs Resveratrol: Which Longevity Supplement Should You Choose?
NMN + Urolithin A + CoQ10?
The same caution applies.
The theoretical roles differ:
NMN
NAD+ biosynthesis.
Urolithin A
Mitochondrial quality control.
CoQ10
Mitochondrial electron transport and redox biology.
There is no robust human evidence demonstrating that combining all three produces superior healthy-aging outcomes.
Read:
Urolithin A vs CoQ10: What’s the Difference and Which Is Better?
Which One Should You Choose?
There is no universal answer.
From a research perspective:
NMN may be more relevant if you are interested in:
- NAD+ biology
- NAD+ precursors
- Cellular metabolism
- Sirtuin-related biology
- Emerging NAD+-aging research
Urolithin A may be more relevant if you are interested in:
- Mitophagy
- Mitochondrial quality control
- Muscle endurance
- Healthy muscle aging
- Muscle-related mitochondrial research
But this does not mean everyone interested in these areas needs a supplement.
The decision should also account for:
- Overall diet
- Exercise habits
- Age
- Health status
- Medications
- Existing medical conditions
- Product quality
- Why supplementation is being considered
What Matters More Than NMN or Urolithin A?
This comparison can easily become too supplement-focused.
The strongest evidence for healthy aging still supports much more fundamental behaviors.
These include:
- Regular resistance training
- Aerobic exercise
- Adequate dietary protein
- A nutrient-dense diet
- Maintaining cardiorespiratory fitness
- Healthy blood pressure
- Appropriate glucose management
- Healthy lipid levels
- Consistent sleep
- Avoiding tobacco
- Limiting excessive alcohol intake
- Maintaining social and cognitive engagement
- Appropriate preventive healthcare
No longevity supplement currently replaces these foundations.
The Bottom Line
So, NMN vs Urolithin A—which is better?
There is no universal winner.
They target different areas of cellular biology.
NMN
Has the clearer evidence for increasing circulating NAD+ and is primarily studied in relation to NAD+-dependent cellular metabolism.
Urolithin A
Has a more focused research program around mitophagy, mitochondrial quality control, muscle endurance, and healthy muscle aging.
But neither has been proven to:
- Reverse aging
- Extend human lifespan
- Prevent age-related disease broadly
- Guarantee greater energy
- Produce clinically meaningful benefits in every healthy adult
The strongest conclusion supported by current evidence is:
NMN and Urolithin A should be viewed as different research compounds with partially complementary biological pathways—not as competing versions of the same supplement and not as proven anti-aging therapies.
Frequently Asked Questions
Is NMN better than Urolithin A?
There is no evidence showing that NMN is universally better. NMN is more directly associated with NAD+ metabolism, while Urolithin A has a more focused research profile around mitophagy and muscle-related mitochondrial biology.
Is Urolithin A better than NMN?
Not universally. Urolithin A may be more relevant to research involving mitochondrial quality control and muscle function, but this does not establish superiority for healthy aging overall.
Does NMN increase NAD+?
Yes. Multiple human studies and systematic reviews have found that oral NMN can increase circulating NAD+ or NAD-related metabolites.
Does higher NAD+ mean slower aging?
Not necessarily. Increasing a biomarker does not automatically prove that aging is slowed or that lifespan is extended.
Does Urolithin A increase NAD+?
Urolithin A is not primarily an NAD+ precursor. Its research focus is more closely related to mitochondrial quality control and mitophagy-related pathways.
Which is better for mitochondria?
They affect different aspects of mitochondrial biology. NMN is connected to NAD+-dependent metabolism, while Urolithin A has a more direct research focus around mitochondrial quality control. No high-quality head-to-head trial has established an overall winner.
Which is better for muscle health?
Urolithin A currently has a more concentrated clinical research program specifically targeting muscle endurance, strength, and mitochondrial biomarkers. NMN has also been studied for physical function, but findings remain mixed.
Can NMN and Urolithin A be taken together?
There is insufficient high-quality human evidence demonstrating that combining the two produces superior clinical outcomes compared with either alone.
Which is better after age 50?
Age alone does not determine which supplement is appropriate. Neither has been established as universally necessary or superior for adults over 50.
Do NMN or Urolithin A extend lifespan?
No. Neither has been proven to extend human lifespan.
Related Celnovix Guides
- Urolithin A Benefits: What Does the Research Actually Show?
- Urolithin A Dosage Guide: How Much Should You Take?
- Best Time to Take Urolithin A: Morning or Night?
- Foods Rich in Urolithin A: Natural Sources and What to Know
- Can You Take NMN and Urolithin A Together? A Complete Guide
- Urolithin A vs Resveratrol: Which Longevity Supplement Should You Choose?
- Urolithin A vs CoQ10: What’s the Difference and Which Is Better?
References
Okabe K, Yaku K, Uchida Y, et al.
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
This randomized, double-blind, placebo-controlled trial evaluated 250 mg/day of NMN for 12 weeks and found a significant increase in whole-blood NAD+.
Zhang J, Poon ETC, Wong SHS.
Efficacy of Oral Nicotinamide Mononucleotide Supplementation on Glucose and Lipid Metabolism for Adults: A Systematic Review With Meta-Analysis on Randomized Controlled Trials.
The review included 12 studies involving 513 participants. NMN significantly increased blood NAD levels, while most clinically relevant glucose and lipid outcomes did not differ significantly from controls.
View the systematic review on PubMed
Chen F, Zhou D, Kong APS, et al.
Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Eight randomized controlled trials involving 342 middle-aged or older adults were reviewed. Short-term NMN supplementation did not significantly improve fasting glucose, fasting insulin, HbA1c, HOMA-IR, or lipid profiles.
Wen J, Syed B, Kim S, et al.
Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide: A Systematic Review of Randomized Control Trials.
This review included 10 randomized trials and 437 participants. Physical-performance findings were generally modest and require confirmation in larger trials.
View the systematic review on PubMed
Andreux PA, Blanco-Bose W, Ryu D, et al.
The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial and Cellular Health in Humans.
Nature Metabolism. 2019.
Read the original study in Nature Metabolism
Liu S, D’Amico D, Shankland E, et al.
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial.
JAMA Network Open. 2022.
Singh A, D’Amico D, Andreux PA, et al.
Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle-Aged Adults.
Cell Reports Medicine. 2022.
Dao T, Nguyen TT, Gariani K, Kim HJ, Ryu D.
Effects of Urolithin A Supplementation on Muscle Health Outcomes in Humans From Randomized Controlled Trials.
Frontiers in Nutrition. 2026.
The systematic review included five randomized controlled trials involving 236 participants. The pooled 6-minute walk test result was directionally favorable but statistically inconclusive, and the certainty of evidence was rated low.
View the 2026 systematic review on PubMed
Editorial Standards
Celnovix publishes evidence-informed educational content about healthy aging, nutrition, supplementation, cellular metabolism, and emerging longevity research.
When comparing supplements, we aim to distinguish between:
- Established biochemical functions
- Human randomized clinical outcomes
- Systematic reviews and meta-analyses
- Biomarker changes
- Mechanistic evidence
- Animal or laboratory research
- Theoretical supplement combinations
- Marketing claims
Increasing a biomarker such as NAD+ does not by itself prove a clinically meaningful anti-aging effect.
Likewise, influencing a pathway such as mitophagy does not by itself prove improved healthspan or longevity.
Articles are periodically reviewed as meaningful new human evidence becomes available.
Medical Disclaimer
This article is provided for general educational and informational purposes only and is not intended as medical advice, diagnosis, prevention, or treatment.
Dietary supplements are not intended to diagnose, treat, cure, or prevent disease.
Clinical-study findings may not apply to every individual, dose, population, supplement combination, or commercial formulation.
If you have a medical condition, take prescription or over-the-counter medications, are pregnant or breastfeeding, are preparing for surgery, or are considering supplements for a specific health concern, consult an appropriately qualified healthcare professional before changing your routine.
